Follow
PharmaLundensis AB
Spotlight (Sweden)
PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.
Sector:
HEALTH CARE
>
Biotechnology
Rights issue
Price
3.00 SEK
Subscription period
05 Mar - 19 Mar 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
PHAL
SE0003359710
Spotlight
Sweden (SE)
Details of share in PharmaLundensis AB with ticker PHAL
Status
Active
Order book id
4110
Amount of instruments
24 661 227
Par value
0.0500
Currency
SEK
First trading date
06 Jul 2010
Type
Price
Pre-money valuation
Time
Files
IPO
2.25 SEK
25.91M SEK
25 May - 08 Jun 2010
IPO in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.00 SEK
68.34M SEK
05 Oct - 31 Oct 2011
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
5.00 SEK
70.91M SEK
04 Apr - 20 Apr 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
5.00 SEK
73.9M SEK
10 Sep - 21 Sep 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
7.00 SEK
110.48M SEK
05 Oct - 12 Oct 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
12.00 SEK
192.99M SEK
03 Jun - 19 Jun 2013
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
12.00 SEK
204M SEK
15 Sep - 17 Oct 2014
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.00 SEK
105.06M SEK
28 Sep - 16 Oct 2015
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.00 SEK
113M SEK
20 Feb - 10 Mar 2017
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.50 SEK
70.98M SEK
04 Apr - 18 May 2018
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
53.19M SEK
19 Oct - 02 Nov 2018
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Convertible issue
15.00 SEK
15 Apr - 17 May 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
44.8M SEK
17 Jun - 01 Jul 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
47.4M SEK
29 Nov - 13 Dec 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Exercise
5.50 SEK
01 Mar - 31 Mar 2020
Option exercise terms for WARRANT 2017/2020
Type
Price
Pre-money valuation
Time
Files
Convertible issue
3.00 SEK
08 May - 25 May 2020
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.00 SEK
24.66M SEK
05 Mar - 19 Mar 2021
Share issue in PharmaLundensis AB
Type
Ticker
ISIN
Market
OPTION
WARRANT 2019/2022
SE0013512043
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker WARRANT 2019/2022
Status
Active
Order book id
Amount of instruments
2 371 296
Currency
SEK
First trading date
Terms
One (1) option entitles the holder to subscribe for one new (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
01 Jun - 30 Jun 2022
01 Dec - 31 Dec 2022
Option exercise terms for WARRANT 2019/2022
Type
Ticker
ISIN
Market
OPTION
PHAL TO5
SE0015659172
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO5
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 1.0 during the subscription period from March 1, 2024 - March 28, 2024.
The Company issues XXX shares.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
01 Mar - 28 Mar 2024
Option exercise terms for PHAL TO5
Type
Ticker
ISIN
Market
SHARE
PHAL
SE0003359710
Spotlight
Sweden (SE)
Details of share in PharmaLundensis AB with ticker PHAL
Status
Active
Order book id
4110
Amount of instruments
24 661 227
Par value
0.0500
Currency
SEK
First trading date
06 Jul 2010
Type
Price
Pre-money valuation
Time
Files
IPO
2.25 SEK
25.91M SEK
25 May - 08 Jun 2010
IPO in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.00 SEK
68.34M SEK
05 Oct - 31 Oct 2011
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
5.00 SEK
70.91M SEK
04 Apr - 20 Apr 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
5.00 SEK
73.9M SEK
10 Sep - 21 Sep 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
7.00 SEK
110.48M SEK
05 Oct - 12 Oct 2012
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
12.00 SEK
192.99M SEK
03 Jun - 19 Jun 2013
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Distribution issue
12.00 SEK
204M SEK
15 Sep - 17 Oct 2014
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.00 SEK
105.06M SEK
28 Sep - 16 Oct 2015
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
6.00 SEK
113M SEK
20 Feb - 10 Mar 2017
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.50 SEK
70.98M SEK
04 Apr - 18 May 2018
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
53.19M SEK
19 Oct - 02 Nov 2018
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Convertible issue
15.00 SEK
15 Apr - 17 May 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
44.8M SEK
17 Jun - 01 Jul 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.00 SEK
47.4M SEK
29 Nov - 13 Dec 2019
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Convertible issue
3.00 SEK
08 May - 25 May 2020
Share issue in PharmaLundensis AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.00 SEK
24.66M SEK
05 Mar - 19 Mar 2021
Share issue in PharmaLundensis AB
Type
Ticker
ISIN
Market
OPTION
WARRANT 2017/2020
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker WARRANT 2017/2020
Status
Archived
Order book id
Amount of instruments
Currency
SEK
First trading date
Terms
The holder of warrants is entitled to subscribe for each warrants of the 2017/2020 series, one (1) new share. Holders of warrants should note that the subscription price significantly exceeds the current market price (closing price February 21: SEK 1.50). Due to the disadvantageous course, no subscription is issued. Should any holder wish to sign despite this, it is possible to contact the company's office in Lund. Warrants that are not exercised by March 31, 2020 will expire.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.50 SEK
01 Mar - 31 Mar 2020
Option exercise terms for WARRANT 2017/2020
Type
Ticker
ISIN
Market
OPTION
WARRANT 2019/2022
SE0013512043
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker WARRANT 2019/2022
Status
Active
Order book id
Amount of instruments
2 371 296
Currency
SEK
First trading date
Terms
One (1) option entitles the holder to subscribe for one new (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
01 Jun - 30 Jun 2022
01 Dec - 31 Dec 2022
Option exercise terms for WARRANT 2019/2022
Type
Ticker
ISIN
Market
OPTION
PHAL TO5
SE0015659172
Spotlight
Sweden (SE)
Details of option in PharmaLundensis AB with ticker PHAL TO5
Status
Inactive
Order book id
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 1.0 during the subscription period from March 1, 2024 - March 28, 2024.
The Company issues XXX shares.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
01 Mar - 28 Mar 2024
Option exercise terms for PHAL TO5
People
Staffan Skogvall
CEO
Arne Skogvall
Chairman of the board
Bo Wennergren
Board member
Björn Sivik
Board member
Ingela Skogvall-Svensson
Board member
Staffan Skogvall
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 22
Zip code
223 63
City/district
Lund
Country
Sweden (SE)
Registration number
556708-8074
LEI code
54930082I88D5N3GQ506
First trade date
06 Jul 2010
Registration date
17 Aug 2016
Short name
PharmaLundensis

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More